Gonzalez-Angulo, A M <br/><br/>
Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.  [electronic resource] 

 -  British journal of cancer  Feb 2015 
 - 630-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2014.647  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Carcinoma, Ductal, Breast--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Paclitaxel--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Retrospective Studies<br/>Trastuzumab